series-c-plus
Stage
1
Investors
About
Codiak develops therapeutics using extracellular vesicles to enable targeted drug delivery for treating complex diseases.
Explore Codiak's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.